Archive: Investment Opportunities
Scale Global Genomic Intelligence.
Secure your positioning at the high-growth intersection of deep-sea exploration and clinical bioinformatics. Deep Sea Genomic is opening its Series A to accelerate therapeutic discovery.
Equity Offered
7.5%
Target Capital
$1.0M USD
Return on Investment (ROI)
5X Return
Market Analysis
GEN-MKT-2024
public
Global Genomic Sequencing Market
| Segment | 2023 (Est) | 2028 (Proj) |
|---|---|---|
| Marine Biotechnology | $5.9B | $9.2B |
| Clinical Bioinformatics | $12.4B | $21.8B |
| Drug Discovery (Oncology) | $48.2B | $76.5B |
explore
Oportunidades en México y LATAM
| Segment | Current | Capture Potential |
|---|---|---|
| Bioprospecting Licenses | $420M | 12% CAGR |
| Research Alliances | $185M | High Barrier |
| Precision Med. Infrastructure | $890M | Gov Tier 1 |
Financial Specimen Data
MODELO-FISCAL-V45-Year Revenue Projection ($ USD M)
Subscription
Licensing
Key Performance Metrics
42%
Internal Rate of Return (IRR)
$12.4M
Net Present Value (NPV)
Mes 18
Estimated Breakeven
Investment Requirements and Allocation
Deep Sea Ops
45%
Deployment of submersibles and sequencing hardware in Mexican territorial waters.
Bio-AI Development
30%
Scaling of proprietary machine learning models for genetic transcription analysis.
IP Protection
15%
Global patent registration for discovered marine genetic sequences and synthetic analogs.
Ops and Legal
10%
Administrative scaling and regulatory compliance for environmental protocols.
Join the Genomic Frontier.
Our data-driven approach minimizes risk by leveraging existing biological blueprints. Join us in translating the ocean's silence into medical breakthroughs.